AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Chronic Obstructive Pulmonary Disease: Epidemiology Forecast to 2028 - ResearchAndMarkets.com

February 3, 2020 GMT

DUBLIN--(BUSINESS WIRE)--Feb 3, 2020--

The “Chronic Obstructive Pulmonary Disease: Epidemiology Forecast to 2028” report has been added to ResearchAndMarkets.com’s offering.

Summary

Chronic Obstructive Pulmonary Disease (COPD) is a progressive disease characterized by coughing that produces large amounts of mucus, difficulty in breathing, shortness of breath (initially with exertion), wheezing, chest tightness, and other respiratory symptoms. The disease is diagnosed based on symptoms and the results of spirometry testing, which measures how deeply a person breathes and how fast air moves in and out of the lungs (World Health Organization, 2017). Spirometry results can also be used to determine the severity of COPD. The most commonly used severity criteria is the Global Initiative for Chronic Obstructive Lung Disease (GOLD) standard.

Epidemiologists utilized county-specific studies published in peer-reviewed journals as well as medical record review studies to build the forecast. The disease definition for COPD was based on symptoms and the results of spirometry testing. The report includes a 10-year epidemiological forecast for the total prevalent and diagnosed prevalent cases of COPD in the 7MM. Epidemiologists followed the GOLD 2011 and GOLD 2016 criteria for the severity stages of COPD in this forecast across the 7MM.

The following data describes epidemiology of COPD. In the 7MM, Epidemiologists forecast an increase in the total prevalent cases of COPD from 59,286,188 cases in 2018 to 67,185,113 cases in 2028 at an AGR of 1.33% during the forecast period. In the 7MM, the diagnosed prevalent cases of COPD will increase from 30,733,034 cases in 2018 to 34,561,468 cases in 2028 at an AGR of 1.25% during the forecast period. COPD is more common in older adults. These trends are reflected in forecast for the total prevalent cases, and diagnosed prevalent cases for the 7MM.

Scope

Reasons to buy

The Chronic Obstructive Pulmonary Disease Epidemiology series will allow you to -

Key Topics Covered:

1 Chronic Obstructive Pulmonary Disease (COPD): Executive Summary

1.1 Catalyst

1.2 Related Reports

1.3 Upcoming Reports

2 Epidemiology

2.1 Disease Background

2.2 Risk Factors and Comorbidities

2.3 Global and Historical Trends

2.4 Forecast Methodology

2.4.1 Sources

2.4.2 Forecast Assumptions and Methods

2.5 Epidemiological Forecast for COPD (2018-2028)

2.5.1 Total Prevalent Cases of COPD

2.5.2 Sex-Specific Total Prevalent Cases of COPD

2.5.3 Age-Specific Total Prevalent Cases of COPD

2.5.4 Diagnosed Prevalent Cases of COPD

2.5.5 Sex-Specific Diagnosed Prevalent Cases of COPD

2.5.6 Age-Specific Diagnosed Prevalent Cases of COPD

2.5.7 Diagnosed Prevalent Cases of COPD by Severity

2.6 Discussion

2.6.1 Epidemiological Forecast Insight

2.6.2 Limitations of the Analysis

2.6.3 Strengths of the Analysis

For more information about this report visit https://www.researchandmarkets.com/r/gtxukr

View source version on businesswire.com:https://www.businesswire.com/news/home/20200203005610/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH OTHER HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2020.

PUB: 02/03/2020 11:50 AM/DISC: 02/03/2020 11:50 AM

http://www.businesswire.com/news/home/20200203005610/en